CORRECTION - Brompton Funds Declare Distributions
TORONTO, ONTARIO -- (Marketwired) -- 01/20/17 -- In the news release, "Brompton Funds Declare Distributions," issued earlier today by Dividend Growth Split Corp. (TSX: DGS), please be advised that additional issuing companies have been added. Complete corrected text follows.
(TSX: DGS)(TSX: LBS)(TSX: LCS)(TSX: LCS.PR.A)(TSX: OSP)(TSX: SBC)
Brompton Funds announces distributions payable on February 14, 2017 to class A shareholders of record at the close of business on January 31, 2017 for each of the following funds:
Fund Name Ticker Amount Per Share Dividend Growth Split Corp. DGS $ 0.10 Life & Banc Split Corp. LBS $ 0.10 Brompton Lifeco Split Corp. LCS $ 0.075 Brompton Oil Split Corp. OSP $ 0.10 Brompton Split Banc Corp. SBC $ 0.10
Brompton Funds also announces distributions payable on February 14, 2017 to preferred shareholders of record at the close of business on January 31, 2017 for the following fund:
Fund Name Ticker Amount Per Share Brompton Lifeco Split Corp. LCS.PR.A $ 0.14375
The funds noted above now offer distribution reinvestment plans ("DRIP") for Class A shareholders which provide Class A shareholders with the ability to automatically reinvest distributions, commission free, and realize the benefits of compound growth. Class A shareholders can enroll in a DRIP program by contacting their investment advisor.
About Brompton Funds
Brompton Funds, a division of Brompton Group which was founded in 2000, is an experienced investment fund manager with approximately $2 billion in assets under management. Brompton's investment solutions include TSX traded funds, mutual funds, and flow-through limited partnerships. For further information, please contact your investment advisor, call Brompton's investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email [email protected] or visit our website at www.bromptongroup.com.
You will usually pay brokerage fees to your dealer if you purchase or sell shares of the investment funds on the Toronto Stock Exchange or other alternative Canadian trading system (an "exchange"). If the shares are purchased or sold on an exchange, investors may pay more than the current net asset value when buying shares of the investment fund and may receive less than the current net asset value when selling them.
There are ongoing fees and expenses associated with owning shares of an investment fund. An investment fund must prepare disclosure documents that contain key information about the funds. You can find more detailed information about the funds in the public filings available at www.sedar.com. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated.
Certain statements contained in this document constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to matters disclosed in this document and to other matters identified in public filings relating to the funds, to the future outlook of the funds and anticipated events or results and may include statements regarding the future financial performance of the funds. In some cases, forward-looking information can be identified by terms such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "intend", "estimate", "predict", "potential", "continue" or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and we assume no obligation to update or revise them to reflect new events or circumstances.
Contacts: Brompton's Investor Relations line 416-642-6000 (toll-free at 1-866-642-6001) [email protected] www.bromptongroup.com
Source: Dividend Growth Split Corp. and Life & Banc Split Corp. and Brompton Split Banc Corp. and Brompton Lifeco Split Corp. and Brompton Oil Split Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quetzal Copper Samples 3.8 M of 2.4% Copper Associated with EM Geophysical Target Extending to 350M Depth at Cristinas Project
- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting
- Future Works Announces Official Launch: Unlocking Leaps in Innovation with Bespoke AI Solutions
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!